Skip to main content
. 2021 Sep 28;6(5):1088–1095. doi: 10.1002/lio2.669

TABLE 2.

Chronological change values of the dysphonic parameters

(Mean ± SE)
2w 4w 8w 12w
Aberrant morae BT −9.9 ± 2.66 b −7.0 ± 2.30 a −6.3 ± 1.90 a −3.5 ± 1.42 a
Placebo −1.1 ± 0.68 −0.2 ± 0.46 −0.3 ± 0.62 0.4 ± 0.43
(S) in GRBAS BT −1.18 ± 0.33 b −0.91 ± 0.37 a −0.73 ± 0.36 a −0.36 ± 0.24
Placebo −0.18 ± 0.18 −0.27 ± 0.36 −0.00 ± 0.19 −0.27 ± 0.30
VHI BT −14.6 ± 7.35 −24.0 ± 9.63 a −20.6 ± 9.91 a −16.7 ± 7.59 a
Placebo −9.8 ± 3.32 −5.3 ± 3.43 −8.0 ± 3.52 −5.7 ± 4.90
VAS BT −11.6 ± 8.67 −20.5 ± 8.74 −18.6 ± 10.53 −15.6 ± 8.68
Placebo −2.0 ± 4.09 −6.2 ± 4.67 −0.2 ± 4.70 −3.2 ± 3.95

Abbreviations: BT, botulinum toxin; VHI, Voice Handicap Index; VAS, visual analogue scale.

a

<0.05 (vs baseline).

b

<0.01 (vs baseline).